Abstract:Mendelian randomization (MR) is an approach to causal inference that utilises genetic variants to obtain estimates of the causal effect of an exposure on an outcome in the presence of unobserved confounding. MR relies on a set of assumptions to obtain unbiased effect estimates, one of these assumptions is that there is no pathway from the genetic variants to the outcome that does not act through the exposure. Increasing genome-wide association study (GWAS) sample sizes for the exposure enables discovery of instrumental variables with smaller effect sizes. We illustrate through simulations how smaller effect sizes could arise from genetic variants that act through traits that have greater liability to confound an exposure-outcome relationship. When such genetic variants are selected as instruments this can bias the MR effect estimate obtained from that instrument in the same direction as the confounded observational association but with larger magnitude. Through simulation we illustrate how the total bias of the MR estimates increases across a range of standard MR estimation methods increases as the proportion of the genetic instruments that are associated with the confounder increases. However, if such heritable confounders are known and can be instrumented, the confounder free effect estimate can be obtained through applying a pre-estimation filtering to standard MR methods, removing instruments that explain more variation in that confounder than the exposure, or by estimating effects through multivariable MR. We highlight the potential for SNPs identified in GWAS to be associated with potential confounders through examination of a recent GWAS of C-Reactive Protein. Finally, we illustrate our approach through estimation of the causal effect of age at menarche on type 2 diabetes, hypothesising that the MR effect estimate may be biased by confounding due to the inclusion of genetic variants associated with early life adiposity as instruments.

MR-GGI: accurate inference of gene–gene interactions using Mendelian randomization

Unveiling challenges in Mendelian randomization for gene–environment interaction

Reciprocal causation mixture model for robust Mendelian randomization analysis using genome-scale summary data

Mendelian randomization for causal inference accounting for pleiotropy and sample structure using genome-wide summary statistics

Mendelian Randomization Analysis in Observational Epidemiology

Mendelian randomization: causal inference leveraging genetic data

Benchmarking Mendelian Randomization methods for causal inference using genome-wide association study summary statistics

Mendelian randomization: genetic anchors for causal inference in epidemiological studies

A robust two-sample Mendelian Randomization method integrating GWAS with multi-tissue eQTL summary statistics

Almost exact Mendelian randomization

Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics

Mendelian Randomization With Refined Instrumental Variables From Genetic Score Improves Accuracy and Reduces Bias

Interpreting findings from Mendelian randomization using the MR-Egger method

Mendelian Randomization: Concepts and Scope

Mendelian randomization analysis using multiple biomarkers of an underlying common exposure

MR.RGM: An R Package for Fitting Bayesian Multivariate Bidirectional Mendelian Randomization Networks

Bias from heritable confounding in Mendelian randomization studies

An integrative multi-context Mendelian randomization method for identifying risk genes across human tissues

Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization

A robust two‐sample transcriptome‐wide Mendelian randomization method integrating GWAS with multi‐tissue eQTL summary statistics

On Mendelian Randomization Mixed-Scale Treatment Effect Robust Identification (MR MiSTERI) and Estimation for Causal Inference